| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 07/16/2003 | EP1327629A1 New 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their processes and uses |
| 07/16/2003 | EP1326943A2 C-nitrosoaniline compounds and their blends as polymerization inhibitors |
| 07/16/2003 | EP1326848A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 07/16/2003 | EP1326847A1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 07/16/2003 | EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/16/2003 | EP1326834A2 2-substituted heterocyclic compounds |
| 07/16/2003 | EP1326833A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/16/2003 | EP1030846B1 Method for producing ar(alk)yluraciles, novel corresponding intermediate products and method for producing said intermediate products |
| 07/16/2003 | EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/16/2003 | EP0758328B1 Anti-cancer compounds containing cyclopentaquinazoline ring |
| 07/16/2003 | CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430608A Substituted iminoazines |
| 07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 07/16/2003 | CN1429821A Monomer containing cycloalkyleneurea and preparing polymer and emulsoid by it |
| 07/16/2003 | CN1114594C D4 receptor selectivity piperazine derivatives |
| 07/15/2003 | US6593488 4-fluoro-3-oxocarboxylic esters and process for producing the same |
| 07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/15/2003 | US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof |
| 07/15/2003 | US6593330 Compounds and their use |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man. |
| 07/10/2003 | WO2003055866A1 Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| 07/10/2003 | WO2003055865A1 Quinazolinone derivative |
| 07/10/2003 | WO2003055864A1 Long chain fatty alcohol substituents in antineoplastic agents |
| 07/10/2003 | WO2003055863A1 Novel alkansulfonamides as endothelin antagonists |
| 07/10/2003 | WO2003055862A1 Method for the chromatographic isolation of ectoine |
| 07/10/2003 | WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
| 07/10/2003 | WO2003055522A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 07/10/2003 | WO2003055492A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 |
| 07/10/2003 | WO2003055490A1 4-arylquinazolines and use thereof as nhe-3 inhibitors |
| 07/10/2003 | WO2003055489A1 2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| 07/10/2003 | WO2003055488A1 Remedies or preventives for diseases in association with tissue fibrosis |
| 07/10/2003 | WO2003055482A1 Amide derivatives as gk activators |
| 07/10/2003 | US20030130506 4-phenoxy or 4-(pyrid-4-yloxy)- benzensulfonic acid derivatives; antitumor and antiarthritic agents |
| 07/10/2003 | US20030130505 Nonsteroidal agonists and antagonists |
| 07/10/2003 | US20030130345 C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 07/10/2003 | US20030130320 Alpha 4 integrin antagonists |
| 07/10/2003 | US20030130296 FXR NR1H4 nuclear receptor binding compounds |
| 07/10/2003 | US20030130295 Substituted 2-aminoacetamides and the use thereof |
| 07/10/2003 | US20030130294 Pyrimidine 3-oxide compounds for inducing/stimulating hair growth and/or retarding hair loss |
| 07/10/2003 | US20030130289 Inhibitors of glycogen synthase kinase 3 |
| 07/10/2003 | US20030130278 Alkynylated fused ring pyrimidine compounds |
| 07/10/2003 | US20030130271 1,3-Diheterocyclic metalloprotease inhibitors |
| 07/10/2003 | US20030130124 Uracil compounds and use thereof |
| 07/10/2003 | US20030130122 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them |
| 07/10/2003 | US20030129670 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential |
| 07/10/2003 | US20030129552 Color photothermography |
| 07/10/2003 | US20030127629 Positive dielectric anisotropy |
| 07/10/2003 | CA2471524A1 4-arylquinazolines and use thereof as nhe-3 inhibitors |
| 07/10/2003 | CA2471348A1 Quinazolinone derivative |
| 07/10/2003 | CA2471049A1 Amide derivatives as gk activators |
| 07/10/2003 | CA2464937A1 Long chain fatty alcohol substituents in antineoplastic agents |
| 07/09/2003 | EP1325916A1 Piperazinyl-substituted phenyl pyrimidine derivatives useful in the treatment or prevention of disorders of the central nervous system |
| 07/09/2003 | EP1325912A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
| 07/09/2003 | CN1429222A 激酶抑制剂 Kinase inhibitors |
| 07/09/2003 | CN1429198A Novel phenyl-proparylether derivatives |
| 07/09/2003 | CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/08/2003 | US6589959 Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid]calcium salt |
| 07/03/2003 | WO2003053971A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | WO2003053967A1 Aroyl pyridinones |
| 07/03/2003 | WO2003053959A1 Heterocyclylamino carbonyluracils |
| 07/03/2003 | WO2003053941A2 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases |
| 07/03/2003 | WO2003053940A1 Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases |
| 07/03/2003 | WO2003053933A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 07/03/2003 | WO2003053927A1 Piperazine derivative |
| 07/03/2003 | WO2003053926A1 Novel phenylalanine derivative |
| 07/03/2003 | WO2003053919A1 Substituted cyclohexane derivatives |
| 07/03/2003 | WO2003053368A2 Chalcone derivatives and their use to treat diseases |
| 07/03/2003 | WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 07/03/2003 | WO2003053360A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/03/2003 | US20030125556 Having an aryl group bonded to a carbon atom in an azomethine moiety and containing amido and amine groups; useful for silver halide photographic photosensitive materials and for printing material in ink jet or thermal printing |
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/03/2003 | US20030125345 Nicotinic compounds; treating central nervous system disorders |
| 07/03/2003 | US20030125338 Compounds, compositions and methods for modulating beta-amyloid production |
| 07/03/2003 | US20030125334 5-HT receptor ligands and uses thereof |
| 07/03/2003 | US20030125329 Treating atherosclerosis and other coronary artery diseases |
| 07/03/2003 | US20030125328 Treating atherosclerosis and other coronary artery diseases |
| 07/03/2003 | US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 07/03/2003 | CA2471089A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | CA2471085A1 Aroyl pyridinones |
| 07/03/2003 | CA2470938A1 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/03/2003 | CA2470931A1 Chalcone derivatives and their use to treat diseases |
| 07/03/2003 | CA2470808A1 Piperazine derivative |
| 07/02/2003 | EP1323709A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 07/02/2003 | EP1322651A1 Bicyclic heteroaromatic compounds |
| 07/02/2003 | EP1322645A2 Quinazolines, medicaments, which contain these compounds and which are effective as tyrosine kinase inhibitors, their use, and methods for the production thereof |
| 07/02/2003 | EP1322639A1 Substituted aryl ketones and their use as herbicides |
| 07/02/2003 | EP1322625A2 Reagents for labeling biomolecules having aldehyde or ketone moieties |
| 07/02/2003 | EP1322624A1 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 07/02/2003 | EP1322623A2 Hydroxy acid integrin antagonists |
| 07/02/2003 | EP1322610A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
| 07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
| 07/02/2003 | EP1322306A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 07/02/2003 | EP1322168A1 Stabilised compositions having antibacterial activity |
| 07/02/2003 | EP0991627B1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 07/02/2003 | EP0757680B1 N-cyanoaryl nitrogen heterocycles |
| 07/02/2003 | CN1427827A 2-Hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/02/2003 | CN1427718A Pharmaceutical compounds for treating COPD |